MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0068545
Impilo Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2019
₹51.17 Lakh
▲ 20% YoY
Net profit · FY 2019
₹1.49 Lakh
Net margin 2.9%
EBITDA · FY 2019
₹2.98 Lakh
EBITDA margin 5.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
6
As per MCA filings
Active GSTINs
1
GST registered
About Impilo Pharmaceuticals Private Limited
Data last updated:
Impilo Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2015PTC078093. Its GSTIN is 29AADCI7118K1Z9 (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Kannambadi Thammaiah Subramaniam (Managing Director) and Vijay Mathodu Eshwarappa (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010.
As per the financials filed for FY 2019, the company reported a revenue of ₹51.17 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 2.9%) and EBITDA of ₹2.98 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Impilo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0068545). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impilopharma.in.
Company Details of Impilo Pharmaceuticals Private Limited
CIN U24232KA2015PTC078093
Registration Number 078093
Incorporation Date 05 January 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0068545
Key People
Kannambadi Thammaiah Subramaniam Managing Director Vijay Mathodu Eshwarappa Whole-Time Director Aruna Mallippanahalli Dharmeshappa Whole-Time Director Recognitions & Rankings of Impilo Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressShed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Impilo Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Impilo Pharmaceuticals Private Limited
The main business activity of Impilo Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Impilo Pharmaceuticals Private Limited FY 2019 filings available
Impilo Pharmaceuticals Private Limited reported revenue of ₹51.17 Lakh (up 20% YoY) for FY 2019.
Revenue · FY 2019
₹51.17 Lakh ▲ 20%
Net profit · FY 2019
₹1.49 Lakh margin 2.9%
EBITDA · FY 2019
₹2.98 Lakh margin 5.8%
Compounded Annual Growth Rate (CAGR) of Impilo Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 77%
Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 20% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Impilo Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹51.17 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.98 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.49 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Impilo Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Impilo Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Ashish Shinge | Additional Director | 02 Aug 2016 | 10 Years 2 Months | Current |
| Vijay Mathodu Eshwarappa | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Aruna Mallippanahalli Dharmeshappa | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Kannambadi Thammaiah Subramaniam | Managing Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Pradeep Tokasandra Siddegowda | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Ravishankar Krishnamurthy | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
Peer Comparison of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bisam Pharmaceuticals Private Limited | ₹51.39 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Jarrot Life Care Private Limited | ₹51.32 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Uttar Pradesh, India |
| Eldora Healthcare Private Limited | ₹51.28 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Mdartis Pharmaceuticals Private Limited | ₹51.26 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Delhi, India |
| Oriens Pharmaceutical Private Limited | ₹51.2 Lakh (FY 2024) | •••• | •••• | 139.0% | •••• | Mumbai, Maharashtra, India |
| Impilo Pharmaceuticals Private Limited this company | ₹51.17 Lakh (FY 2019) | •••• | •••• | 20.0% | •••• | Bangalore, Karnataka, India |
| Hindava Pharmaceuticals Private Limited | ₹51.17 Lakh (FY 2025) | •••• | •••• | 9375.0% | •••• | Hyderabad, Telangana, India |
| Seashell Laboratories Private Limited | ₹51.13 Lakh (FY 2018) | •••• | •••• | •••• | Dombivili West Thane, Maharashtra, India | |
| Pepcura Pharmaceuticals Private Limited | ₹51.12 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Raipur, Chhattisgarh, India |
| Mobanit Industries Private Limited | ₹51.1 Lakh (FY 2025) | •••• | •••• | 1773.0% | •••• | Salem, Tamil Nadu, India |
| SBM Pharmaceuticals Private Limited | ₹51.04 Lakh (FY 2021) | •••• | •••• | -15.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Impilo Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals Private Limited is audited by N RAVI & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N RAVI & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Impilo Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by M/S Apple Biotech | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Impilo Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Impilo Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals Private Limited has 6 board changes on record since 2015: 6 appointments. The latest: Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016.
AGM
Impilo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Impilo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore.
Appointed
Sandhya Ashish Shinge was appointed as Additional Director.
Appointed
Aruna Mallippanahalli Dharmeshappa was appointed as Whole-Time Director.
Appointed
Kannambadi Thammaiah Subramaniam was appointed as Managing Director.
Appointed
Pradeep Tokasandra Siddegowda was appointed as Whole-Time Director.
Appointed
Ravishankar Krishnamurthy was appointed as Whole-Time Director.
Appointed
Vijay Mathodu Eshwarappa was appointed as Whole-Time Director.
Incorporation
05 Jan 2015
Impilo Pharmaceuticals Private Limited was registered on 05 Jan 2015 with Roc Bangalore & aged 11 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Impilo Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Impilo Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Impilo Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCI7118K1Z9 | Karnataka | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Impilo Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2015 (11+ years old) and is registered under CIN U24232KA2015PTC078093.
Impilo Pharmaceuticals reported revenue of ₹51.17 Lakh for FY 2019 (up 20% YoY).
Impilo Pharmaceuticals has 6 current directors:
- Kannambadi Thammaiah Subramaniam - Managing Director
- Vijay Mathodu Eshwarappa - Whole-Time Director
- Aruna Mallippanahalli Dharmeshappa - Whole-Time Director
- Pradeep Tokasandra Siddegowda - Whole-Time Director
- Ravishankar Krishnamurthy - Whole-Time Director
- Sandhya Ashish Shinge - Additional Director
Impilo Pharmaceuticals reported a net profit of ₹1.49 Lakh (net margin 2.9%) and EBITDA of ₹2.98 Lakh (EBITDA margin 5.8%) for FY 2019, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Impilo Pharmaceuticals is 45% over three years. In the latest year (FY 2019) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Impilo Pharmaceuticals is 29AADCI7118K1Z9, registered in Karnataka.
The CIN (Corporate Identification Number) of Impilo Pharmaceuticals is U24232KA2015PTC078093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Impilo Pharmaceuticals has 1 court case on record: 1 filed against it.
Impilo Pharmaceuticals was incorporated on 05 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Impilo Pharmaceuticals by revenue are Bisam Pharmaceuticals Private Limited, Jarrot Life Care Private Limited, Eldora Healthcare Private Limited, Mdartis Pharmaceuticals Private Limited, Oriens Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016. Aruna Mallippanahalli Dharmeshappa was appointed as Whole-Time Director on 05 Jan 2015. Kannambadi Thammaiah Subramaniam was appointed as Managing Director on 05 Jan 2015. Impilo Pharmaceuticals has 6 board changes on record in total.